Last updated at 08 Oct 2024 03:11 PM
Director
DIN: 07932761
Raghavan Rangarajan is currently associated with 3 companies as Director. They serve as a Director at ACCEL LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07932761.Raghavan Rangarajan has previously been associated with 7 companies in roles such as Additional Director, Director and Managing Director.Raghavan Rangarajan is currently involved in 1 different role. Their most recent position is with CLARITAS MEDICARE PRIVATE LIMITED as a Director. The first company Raghavan Rangarajan was appointed to as a director was ACCEL LIMITED. Raghavan Rangarajan is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Raghavan Rangarajan is currently associated with 3 companies as Director. They serve as a Director at ACCEL LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07932761.Raghavan Rangarajan has previously been associated with 7 companies in roles such as Additional Director, Director and Managing Director.Raghavan Rangarajan is currently involved in 1 different role. Their most recent position is with CLARITAS MEDICARE PRIVATE LIMITED as a Director. The first company Raghavan Rangarajan was appointed to as a director was ACCEL LIMITED. Raghavan Rangarajan is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (7)
1y 8m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ACCEL LIMITED | Director | 28-Sep-2022 |
| SIGHTGENICS RESEARCH PRIVATE LIMITED | Director | 09-Aug-2023 |
| CLARITAS MEDICARE PRIVATE LIMITED | Director | 11-Sep-2024 |